Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 3 of 60 found articles
 
 
  510 Addition of All-Trans Retinoic Acid (ATRA) to the Combination of Fludarabine, Cytarabine, Idarubicin, With or Without GCSF in Older, Higher Risk Patients with AML and High-Risk MDS Does Not Improve the Outcome in Those with NPM1 Mutation
 
 
Title: 510 Addition of All-Trans Retinoic Acid (ATRA) to the Combination of Fludarabine, Cytarabine, Idarubicin, With or Without GCSF in Older, Higher Risk Patients with AML and High-Risk MDS Does Not Improve the Outcome in Those with NPM1 Mutation
Author: Malik, Asifa
Bueso-Ramos, Carlos
Faderl, Stefan
Estey, Eli
O'Brien, Susan
Fernandez, Michael
Nguyen, Martin
Koller, Charles
Freireich, Emil
Beran, Miloslav
Pierce, Sherry
Cortes, Jorge
Kantarjian, Hagop
Ravandi, Farhad
Appeared in: Clinical lymphoma myeloma and leukemia
Paging: Volume 11 (2011) nr. S1 pages 2 p.
Year: 2011
Contents:
Publisher: Elsevier Inc.
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 3 of 60 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands